Drug Use Investigation of Selara Tablets (an Investigation for Chronic Heart Failure)

  • STATUS
    Not Recruiting
  • participants needed
    1000
  • sponsor
    Pfizer
Updated on 21 June 2021
Investigator
Pfizer CT.gov Call Center
Primary Contact
Pfizer Local Country Office (1.8 mi away) Contact

Summary

Secondary Data Collection Study; Safety And Effectiveness Of Selara Under Japanese Medical Practice

Description

This study will be conducted under the central registration system until the number of subjects who meet the conditions for registration reaches the target number of subjects. The patients will be observed up until Week 52.

Details
Condition Chronic Heart Failure
Treatment Eplerenone
Clinical Study IdentifierNCT03342690
SponsorPfizer
Last Modified on21 June 2021

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note